Introduction Gait rehabilitation after a stroke is a major concern in physical medicine and rehabilitation. Since 2007, « Le Normandy» rehabilitation center is equipped with robotic assisted gait training named “Lokomat”; vascular hemiplegic patients benefit from it. This study was conducted to investigate the effect of Lokomat on the walking performance of hemiplegic patients after a stroke and to identify the influence of certain factors.

Methods This was a retrospective, observational study conducted at « Le Normandy » rehabilitation center in Granville, France. All adult patients hospitalized between 2007 and 2018 for a first stroke within the last six months who completed a full Lokomat program were included. Medical data were collected : sex, age, type of stroke, time since the onset, modified Functional Ambulation Category (mFAC), date of stroke and results of the six minutes walking test (6MWT) before and after rehabilitation. The outcome was the difference between the 6MWT before and after the rehabilitation to determine the evolution of the walking capacity and factors associated with a gain.

Results We included 235 patients. The median gain on the 6MWT was 18 meters (p<0,01). Two factors were significantly associated with the 6MWT gain : rehabilitation phase and severity of stroke. The median gain was 21.22 meters (95% CI [1.86 ; 44.93]) for patients in early rehabilitation phase versus late rehabilitation phase. The median gain was 34.22 meters (95% CI [16.20 ; 74.69]) for ambulatory patients at the onset compared to non-ambulatory patient. There were no significant difference of median gain between men and women (3.22 meters 95% CI [−11.86 ; 19.48]), between ischemic and hemorrhagic strokes (1.67 meters 95% CI [−10.59 ; 17.03]) and between the post-2016 and pre-2016 periods (6.22 meters 95% CI [−7.99 ; 32.78]). There was a decrease of 0.56 meters (95% CI [−0.99 ; 0.16]) per year at the 6MWT, and this result was not significant.

Conclusion There was a significant improvement in the 6MWT after robotic rehabilitation by Lokomat. This improvement was greater in patients in early rehabilitation phase and when the patient was initially ambulatory.

The authors have declared no competing interest.

No funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The protocol was approved by ethics committee of the university hospital of Caen, France.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

all data referred to in the manuscript are available